LANXESS Aktiengesellschaft (LXS) - Net Assets
Based on the latest financial reports, LANXESS Aktiengesellschaft (LXS) has net assets worth €3.91 Billion EUR (≈ $4.57 Billion USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€8.18 Billion ≈ $9.57 Billion USD) and total liabilities (€4.28 Billion ≈ $5.00 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check LANXESS Aktiengesellschaft (LXS) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €3.91 Billion |
| % of Total Assets | 47.76% |
| Annual Growth Rate | 8.35% |
| 5-Year Change | 53.12% |
| 10-Year Change | 97.68% |
| Growth Volatility | 19.97 |
LANXESS Aktiengesellschaft - Net Assets Trend (2013–2024)
This chart illustrates how LANXESS Aktiengesellschaft's net assets have evolved over time, based on quarterly financial data. Also explore LXS total assets for the complete picture of this company's asset base.
Annual Net Assets for LANXESS Aktiengesellschaft (2013–2024)
The table below shows the annual net assets of LANXESS Aktiengesellschaft from 2013 to 2024. For live valuation and market cap data, see LANXESS Aktiengesellschaft stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €4.59 Billion ≈ $5.37 Billion |
+1.89% |
| 2023-12-31 | €4.51 Billion ≈ $5.27 Billion |
+1.81% |
| 2022-12-31 | €4.43 Billion ≈ $5.18 Billion |
+17.68% |
| 2021-12-31 | €3.76 Billion ≈ $4.40 Billion |
+25.44% |
| 2020-12-31 | €3.00 Billion ≈ $3.51 Billion |
+13.30% |
| 2019-12-31 | €2.65 Billion ≈ $3.09 Billion |
-4.54% |
| 2018-12-31 | €2.77 Billion ≈ $3.24 Billion |
-18.75% |
| 2017-12-31 | €3.41 Billion ≈ $3.99 Billion |
-8.45% |
| 2016-12-31 | €3.73 Billion ≈ $4.36 Billion |
+60.48% |
| 2015-12-31 | €2.32 Billion ≈ $2.72 Billion |
+7.50% |
| 2014-12-31 | €2.16 Billion ≈ $2.53 Billion |
+13.74% |
| 2013-12-31 | €1.90 Billion ≈ $2.22 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to LANXESS Aktiengesellschaft's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1800000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €4.76 Billion | 103.86% |
| Total Equity | €4.59 Billion | 100.00% |
LANXESS Aktiengesellschaft Competitors by Market Cap
The table below lists competitors of LANXESS Aktiengesellschaft ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Formula
TA:FORTY
|
$1.70 Billion |
|
Acuren Corporation
NYSE:TIC
|
$1.70 Billion |
|
Shanghai Waigaoqiao Free Trade Zone Group Co Ltd A
SHG:600648
|
$1.70 Billion |
|
Shanxi Zhangze Electric Power Co Ltd
SHE:000767
|
$1.70 Billion |
|
Jungfraubahn Holding AG
SW:JFN
|
$1.70 Billion |
|
Cimpress plc
F:3UF
|
$1.70 Billion |
|
Lithium Americas Corp
TO:LAC
|
$1.70 Billion |
|
Dürr Aktiengesellschaft
F:DUE
|
$1.70 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in LANXESS Aktiengesellschaft's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 4,501,000,000 to 4,586,000,000, a change of 85,000,000 (1.9%).
- Net loss of 177,000,000 reduced equity.
- Dividend payments of 9,000,000 reduced retained earnings.
- Other factors increased equity by 271,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-177.00 Million | -3.86% |
| Dividends Paid | €9.00 Million | -0.2% |
| Other Changes | €271.00 Million | +5.91% |
| Total Change | €- | 1.89% |
Book Value vs Market Value Analysis
This analysis compares LANXESS Aktiengesellschaft's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.33x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 0.71x to 0.33x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €24.99 | €17.69 | x |
| 2018-12-31 | €30.37 | €17.69 | x |
| 2019-12-31 | €30.52 | €17.69 | x |
| 2020-12-31 | €34.76 | €17.69 | x |
| 2021-12-31 | €43.50 | €17.69 | x |
| 2022-12-31 | €51.20 | €17.69 | x |
| 2023-12-31 | €52.13 | €17.69 | x |
| 2024-12-31 | €53.11 | €17.69 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently LANXESS Aktiengesellschaft utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -3.86%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2.78%
- • Asset Turnover: 0.66x
- • Equity Multiplier: 2.12x
- Recent ROE (-3.86%) is below the historical average (6.97%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -8.39% | -1.92% | 1.22x | 3.59x | €-348.50 Million |
| 2014 | 2.18% | 0.59% | 1.10x | 3.36x | €-168.90 Million |
| 2015 | 7.14% | 2.09% | 1.09x | 3.13x | €-66.00 Million |
| 2016 | 7.52% | 2.49% | 0.78x | 3.87x | €-63.20 Million |
| 2017 | 3.80% | 0.90% | 0.93x | 4.55x | €-141.70 Million |
| 2018 | 15.50% | 5.99% | 0.83x | 3.12x | €153.00 Million |
| 2019 | 7.68% | 3.01% | 0.78x | 3.26x | €-61.90 Million |
| 2020 | 29.49% | 14.50% | 0.69x | 2.96x | €584.90 Million |
| 2021 | 7.11% | 3.53% | 0.72x | 2.80x | €-108.60 Million |
| 2022 | 5.65% | 3.09% | 0.72x | 2.55x | €-192.10 Million |
| 2023 | 9.84% | 6.60% | 0.69x | 2.15x | €-7.10 Million |
| 2024 | -3.86% | -2.78% | 0.66x | 2.12x | €-635.60 Million |
Industry Comparison
This section compares LANXESS Aktiengesellschaft's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $3,039,854,957
- Average return on equity (ROE) among peers: -28.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| LANXESS Aktiengesellschaft (LXS) | €3.91 Billion | -8.39% | 1.09x | $1.70 Billion |
| GRAPHENE MANUFACT.GROUP (0GF) | $8.54 Million | -86.66% | 0.78x | $152.93 Million |
| Orion Engineered Carbons SA (0OE) | $474.90 Million | 9.31% | 2.91x | $318.41 Million |
| H&R GmbH & Co. KGaA (2HRA) | $471.16 Million | 9.06% | 1.04x | $183.88 Million |
| Dotz Nano Ltd (57N) | $421.99K | -248.22% | 1.80x | $3.81 Million |
| EXPLOS. PROD. CHIM.EO 31 (9Z50) | $144.93 Million | 14.73% | 2.07x | $536.15 Million |
| Altech Chemicals Ltd (A3Y) | $88.93 Million | 2.62% | 0.01x | $27.76 Million |
| AlzChem Group AG (ACT) | $68.66 Million | 28.68% | 4.16x | $1.83 Billion |
| AIR LIQUIDE ADR 1/5/EO 11 (AILA) | $24.57 Billion | 11.23% | 1.02x | $103.86 Billion |
| AKZO NOBEL SPONS.ADRS 1/3 (AKUP) | $4.55 Billion | 9.72% | 2.20x | $8.57 Billion |
| BRAIN Biotech AG (BNN) | $23.01 Million | -35.97% | 2.08x | $51.56 Million |
About LANXESS Aktiengesellschaft
LANXESS Aktiengesellschaft, a specialty chemicals company, engages in the development, manufacture, and marketing of chemical intermediates, additives, and consumer protection products worldwide. It operates through three segments: Consumer Protection, Specialty Additives, and Advanced Intermediates. The company provides material protection products; disinfectant, hygiene, and preservative soluti… Read more